CTC researchers and their collaborators have a strong record of published research in prestigious international journals. Recent journal articles are listed here.

Use the search link below to find specific articles, or articles by year, author, trial or group, back to 2007.

Search for articles


Abbott L M, Magnusson R S, Gibbs E, Smith S D Smartphone use in dermatology for clinical photography and consultation: current practice and the law. Australasian Journal of Dermatology 2017;

Alam P, Guzman Rojas R, Kamisan Atan I, Mann K, Dietz H P The 'bother' of obstructed defecation. Ultrasound in Obstetrics and Gynecology 2017;  49 (3): 394–397.

Alexander BM, Ba S, Berger MS, Berry DA, Cavenee WK, Chang SM, Cloughesy TF, Jiang T, Khasraw M, Li W, Mittman R, Poste GH, Wen PY, Yung WKA, Barker AD Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE. Clinical Cancer Research 2017;

Arnott C, Strange G, Bullock A, Kirby A C, O'Donnell C, Radford D J, Grigg L E, Celermajer D S Pulmonary vasodilator therapy is associated with greater survival in Eisenmenger syndrome. Heart 2017;

Askie L M, Darlow B A, Davis P G, Finer N, Stenson B, Vento M, Whyte R Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants. Cochrane Database of Systematic Reviews 2017;  4: CD011190. Full text

Bai P Y, Wittert G, Taylor A W, Martin S A, Milne R W, Jenkins A J, Januszewski A S, Shi Z The association between total phthalate concentration and non-communicable diseases and chronic inflammation in South Australian urban dwelling men. Environmental Research 2017;  158: 366–372.

Bamias A, Gibbs E, Khoon Lee C, Davies L, Dimopoulos M, Zagouri F, Veillard A S, Kosse J, Santaballa A, Mirza M R, Tabaro G, Vergote I, Bloemendal H, Lykka M, Floquet A, Gebski V, Pujade-Lauraine E Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial. Annals of Oncology 2017;

Barz C, Melloh M, Staub L P, Lord S J, Merk H R, Barz T Reversibility of nerve root sedimentation sign in lumbar spinal stenosis patients after decompression surgery. European Spine Journal 2017;

Bell K J, Mehta Y, Turner R M, Morton R L, Dieng M, Saw R, Guitera P, McCaffery K, Low D, Low C, Jenkins M, Irwig L, Webster A C Fear of new or recurrent melanoma after treatment for localised melanoma. Psycho-Oncology 2017;

Bonaventura A, O'Connell R L, Mapagu C, Beale P J, McNally O M, Mileshkin L R, Grant P T, Hadley A M, Goh J C H, Sjoquist K M, Martyn J, DeFazio A, Scurry J, Friedlander M L Paragon (ANZGOG-0903): phase 2 study of anastrozole in women with estrogen or progesterone receptor-positive platinum-resistant or -refractory recurrent ovarian cancer. International Journal of Gynecological Cancer 2017;  27 (5): 900–906.

Brakoulias V, Starcevic V, Belloch A, Brown C, Ferrao Y A, Fontenelle L F, Lochner C, Marazziti D, Matsunaga H, Miguel E C, Reddy Y, do Rosario M C, Shavitt R G, Shyam Sundar A, Stein D J, Torres A R, Viswasam K Comorbidity, age of onset and suicidality in obsessive-compulsive disorder (OCD): An international collaboration. Comprehensive Psychiatry 2017;  76: 79–86.

Brazionis L, Jenkins A, Keech A, Ryan C, Bursell S E An evaluation of the telehealth facilitation of diabetes and cardiovascular care in remote Australian Indigenous communities: protocol for the telehealth eye and associated medical services network [TEAMSnet] project, a pre–post study design. BMC Health Services Research 2017;  17 (1): 13. Full text

Burgess N G, Hourigan L F, Zanati S A, Brown G J, Singh R, Williams S J, Raftopoulos S C, Ormonde D, Moss A, Byth K, Mahajan H, McLeod D, Bourke M J Risk stratification for covert invasive cancer among patients referred for colonic endoscopic mucosal resection: a large multi-center cohort. Gastroenterology 2017;

Calopedos R J S, Chalasani V, Asher R, Emmett L, Woo H H Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases 2017;

Carr D, Barnes E H, Gordon A, Isaacs D Effect of antibiotic use on antimicrobial antibiotic resistance and late-onset neonatal infections over 25 years in an Australian tertiary neonatal unit. Archives of Disease in Childhood. Fetal and Neonatal  2017;  102 (3): F244–F250.

Caskey F J, Morton R L Optimising care for children with kidney disease. Lancet 2017;  389 (10084): 2084–2086.

Caudwell-Hall J, Atan I K, Martin A, Rojas R G, Langer S, Shek K, Dietz H P Intrapartum predictors of maternal levator ani injury. Acta Obstetricia et Gynecologica Scandinavica 2017;  96 (4): 426–431.

Chan D L, Sjoquist K M, Goldstein D, Price T J, Martin A J, Bang Y J, Kang Y K, Pavlakis N The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: a systematic review and meta-analysis. PLoS One 2017;  12 (2): e0172307. Full text

Chim L, Salkeld G, Kelly P, Lipworth W, Hughes D A, Stockler M R Societal perspective on access to publicly subsidised medicines: a cross sectional survey of 3080 adults in Australia. PLoS One 2017;  12 (3): e0172971. Full text

Chin S, Hayden A J, Gebski V, Cross S, Turner S L Long term patient reported urinary function following external beam radiotherapy for prostate cancer. Clinical Oncology (Royal College of Radiologists) 2017;  29 (7): 421–428.

Cho Y H, Craig M E, Januszewski A S, Benitez-Aguirre P, Hing S, Jenkins A J, Donaghue K C Higher skin autofluorescence in young people with type 1 diabetes and microvascular complications. Diabetic Medicine 2017;  34 (4): 543–550.

Clark W, Bird P, Diamond T, Gonski P, Barnes E, Gebski V Criticisms of the VAPOUR trial in a recent commentary are unsubstantiated and incorrect. Evidence-Based Medicine 2017;  22 (3): 116–117.

Conroy R, Gebski V, Latty D, Wang T, Stuart K, Ahern V Whole breast hypofractionation: trials, guidelines and clinical practice [letter]. Journal of Medical Imaging and Radiation Oncology 2017;  61 (1): 157–158.

Critselis E, Vlahou A, Stel VS, Morton RL Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion. Nephrology Dialysis Transplantation 2017; Full text

Damian D L, Martin A J, Scolyer R A, Chen A C, Halliday G M Reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients': reply from the authors [letter]. British Journal of Dermatology 2017;  176 (2): 552–553.

Daniels B, Lord S J, Kiely B E, Houssami N, Haywood P, Lu C Y, Ward R L, Pearson S A Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort. BMJ Open 2017;  7 (1): e014439. Full text

Deveza LA, Hunter DJ, Wajon A, Bennell KL, Vicenzino B, Hodges P, Eyles JP, Jongs R, Riordan EA, Duong V, Min Oo W, O'Connell R, Meneses SRF Efficacy of combined conservative therapies on clinical outcomes in patients with thumb base osteoarthritis: protocol for a randomised, controlled trial (COMBO). BMJ Open 2017;  7: e014498. Full text

Ding P N, Lord S J, Gebski V, Links M, Bray V, Gralla R J, Yang J C, Lee C K Risk of treatment-related toxicities from EGFR tyrosine kinase inhibitors: a meta-analysis of clinical trials of gefitinib, erlotinib and afatinib in advanced EGFR-mutated non-small-cell lung cancer. Journal of Thoracic Oncology 2017;  12 (4): 633–643.

Donoghoe M W, Gebski V The importance of censoring in competing risks analysis of the subdistribution hazard. BMC Medical Research Methodology 2017;  17 (1): 52. Full text

Driscoll A, Barnes E H, Blankenberg S, Colquhoun D M, Hunt D, Nestel P J, Stewart R A, West M J, White H D, Simes J, Tonkin A Predictors of incident heart failure in patients after an acute coronary syndrome: the LIPID heart failure risk-prediction model. International Journal of Cardiology 2017;

Duchesne G M, Woo H H, King M, Bowe S J, Stockler M R, Ames A, D'Este C, Frydenberg M, Loblaw A, Malone S, Millar J, Tai K H, Turner S Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial. Lancet Oncology 2017;

Egger S J, Willson M L, Morgan J, Walker H S, Carrick S, Ghersi D, Wilcken N Platinum-containing regimens for metastatic breast cancer. Cochrane Database of Systematic Reviews 2017;  2017 (6): CD003374. Full text

Emery J D, Jefford M, King M, Hayne D, Martin A, Doorey J, Hyatt A, Habgood E, Lim T, Hawks C, Pirotta M, Trevena L, Schofield P ProCare trial: a phase II randomized controlled trial of shared care for follow-up of men with prostate cancer. BJU International 2017;  119 (3): 381–389.

Farid-Kapadia M, Askie L, Hartling L, Contopoulos-Ioannidis D, Bhutta Z A, Soll R, Moher D, Offringa M Do systematic reviews on pediatric topics need special methodological considerations?. BMC Pediatrics 2017;  17 (1): 57. Full text

Field K M, King M T, Simes J, Espinoza D, Barnes E H, Sawkins K, Rosenthal M A, Cher L, Hovey E, Wheeler H, Nowak A K Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma. Journal of Neuro-Oncology 2017;

Field K M, Phal P M, Fitt G, Goh C, Nowak A K, Rosenthal M A, Simes J, Barnes E H, Sawkins K, Cher L M, Hovey E J, Wheeler H The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET). Cancer 2017;

Fisher O M, Lord S J, Falkenback D, Clemons N J, Eslick G D, Lord R V The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis. Gut 2017;  66 (3): 399–410. Full text

Gebski V, Gibbs E, Gandhi M, Chatellier G, Dinut A, Pereira H, Chow P K, Vilgrain V VESPRO: an individual patient data prospective meta-analysis of selective internal radiation therapy versus sorafenib for advanced, locally advanced, or recurrent hepatocellular carcinoma of the SARAH and SIRveNIB trials. JMIR Research Protocols 2017;  6 (2): e17. Full text

Gebski V, Janda M, Obermair A Survival after laparoscopic vs abdominal hysterectomy: reply [letter]. JAMA 2017;  318 (6): 574–575. Full text

Gendron D R, Lecours P B, Lemay A M, Beaulieu M J, Huppé C A, Lee-Gosselin A, Flamand N, Don A S, Bissonnette É, Blanchet M R, Laplante M, Bourgoin S G, Bossé Y, Marsolais D A phosphorylatable sphingosine analog induces airway smooth muscle cytostasis and reverses airway hyperresponsiveness in experimental asthma. Frontiers in Pharmacology 2017;  8 (Feb): 78.

Giugliano R P, Mach F, Zavitz K, Kurtz C, Im K, Kanevsky E, Schneider J, Wang H, Keech A, Pedersen T R, Sabatine M S, Sever P S, Robinson J G, Honarpour N, Wasserman S M, Ott B R Cognitive function in a randomized trial of evolocumab. New England Journal of Medicine 2017;  377 (7): 633–643. Full text

Giugliano R P, Mach F, Zavitz K, Kurtz C, Schneider J, Wang H, Keech A, Pedersen T R, Sabatine M S, Sever P S, Honarpour N, Wasserman S M, Ott B R Design and rationale of the EBBINGHAUS trial: a phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid-lowering therapy. A cognitive study of patients enrolled in the FOURIER trial. Clinical Cardiology 2017;  40 (2): 59–65. Full text

Graf A, McAuley S A, Sims C, Ulloa J, Jenkins A J, Voskanyan G, O'Neal D N Moving toward a unified platform for insulin delivery and sensing of inputs relevant to an artificial pancreas. Journal of Diabetes Science and Technology 2017;  11 (2): 308–314.

Graf A, Ward G M, Vogrin S, Sundararajan V, Sharifi A, De Bock M I, Jayawardene D, Loh M M, Horsburgh J C, Berthold C L, Paramalingam N, Bach L A, Colman P G, Davis E A, Grosman B, Jenkins A J, Kumareswaran K, Kurtz N, Kyoong A, MacIsaac R J, Roy A, Jones T W, O'Neal D N Overnight counter-regulatory hormone levels and next day glycemia in adults with type 1 diabetes during closed-loop insulin delivery versus sensor-augmented pump with low-glucose suspend. Diabetes Technology & Therapeutics 2017;  19 (7): 438–439.

Gray B, Kirby A, Kabunga P, Freedman S B, Yeates L, Kanthan A, Medi C, Keech A, Semsarian C, Sy R W Twelve-lead ambulatory electrocardiographic monitoring in Brugada syndrome: Potential diagnostic and prognostic implications. Heart Rhythm 2017;  14 (6): 866–874.

Hakami N Y, Ranjan A K, Hardikar A A, Dusting G J, Peshavariya H M Role of NADPH oxidase-4 in human endothelial progenitor cells. Frontiers in Physiology 2017;  8: 150. Full text

Harris C, Ko H, Waller C, Sloss P, Williams P Sustainability in health care by allocating resources effectively (SHARE) 4: exploring opportunities and methods for consumer engagement in resource allocation in a local healthcare setting. BMC Health Services Research 2017;  17 (1): 329. Full text

Hayne D, Stockler M, McCombie S P, Lawrence N, Martin A, Sengupta S, Davis I D The BCG + mitomycin trial for high risk non-muscle-invasive bladder cancer: progress report and lessons learned. BJU International 2017;  119 (Suppl. 5): 55–57.

Heiniger L E, Smith A B, Olver I, Grimison P, Klein B, Wootten A, Abbott J M, Price M A, McJannett M, Tran B, Stockler M R, Gurney H, Butow P N e-TC: Development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer. European Journal of Cancer Care (English Language Edition) 2017;

Hendrieckx C, Hagger V, Jenkins A, Skinner T C, Pouwer F, Speight J Severe hypoglycemia, impaired awareness of hypoglycemia, and self-monitoring in adults with type 1 diabetes: results from Diabetes MILES—Australia. Journal of Diabetes and its Complications 2017;  31 (3): 577–582.

Houssami N, Hunter K The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening. NPJ Breast Cancer 2017;  3: 12. Full text

Hovey EJ, Field KM, Rosenthal MA, Barnes EH, Cher L, Nowak AK, Wheeler H, Sawkins K, Livingstone A, Phal P, Goh C, Simes J, on behalf of CABARET/COGNO investigators. Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial. Neuro-Oncology Practice 2017;

Itchins M, Arena J, Nahm C B, Rabindran J, Kim S, Gibbs E, Bergamin S, Chua T C, Gill A J, Maher R, Diakos C, Wong M, Mittal A, Hruby G, Kneebone A, Pavlakis N, Samra J, Clarke S Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centre. European Journal of Surgical Oncology 2017;

Janda M, Gebski V, Davies L C, Forder P, Brand A, Hogg R, Jobling T W, Land R, Manolitsas T, Nascimento M, Neesham D, Nicklin J L, Oehler M K, Otton G, Perrin L, Salfinger S, Hammond I, Leung Y, Sykes P, Ngan H, Garrett A, Laney M, Ng T Y, Tam K, Chan K, Wrede C D, Pather S, Simcock B, Farrell R, Robertson G, Walker G, Armfield N R, Graves N, McCartney A J, Obermair A Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage I endometrial cancer: a randomized clinical trial. JAMA 2017;  317 (12): 1224–1233.

Jayawardene D C, McAuley S A, Horsburgh J C, La Gerche A, Jenkins A J, Ward G M, MacIsaac R J, Roberts T J, Grosman B, Kurtz N, Roy A, O'Neal D N Closed-loop insulin delivery for adults with type 1 diabetes undertaking high-intensity interval exercise versus moderate-intensity exercise: a randomized, crossover study. Diabetes Technology and Therapeutics 2017;  19 (6): 340–348.

Joseph P D, Caldwell P H, Barnes E H, Craig J C Disease burden-research match? Registered trials in child health from low- and middle-income and high-income countries. Journal of Paediatrics and Child Health 2017;  53 (7): 667–674.

Karikios D J, Chim L, Martin A, Nagrial A, Howard K, Salkeld G, Stockler M R Is it all about price? Why requests for government subsidy of anticancer drugs were rejected in Australia. Internal Medicine Journal 2017;  47 (4): 400–407.

Karikios D J, Mileshkin L, Martin A, Ferraro D, Stockler M R Discussing and prescribing expensive unfunded anticancer drugs in Australia. ESMO Open 2017;  2 (2): e000170. Full text

Keall P, Nguyen D T, O'Brien R, Booth J, Greer P, Poulsen P, Gebski V, Kneebone A, Martin J Stereotactic prostate adaptive radiotherapy utilising kilovoltage intrafraction monitoring: the TROG 15.01 SPARK trial. BMC Cancer 2017;  17 (1): 180. Full text

Korevaar D A, Hooft L, Askie L M, Barbour V, Faure H, Gatsonis C A, Hunter K E, Kressel H Y, Lippman H, McInnes M D, Moher D, Rifai N, Cohen J F, Bossuyt P M Facilitating prospective registration of diagnostic accuracy studies: a STARD initiative. Clinical Chemistry 2017;  63 (8): 1331–1341.

Lee C K, Davies L, Wu Y L, Mitsudomi T, Inoue A, Rosell R, Zhou C, Nakagawa K, Thongprasert S, Fukuoka M, Lord S, Marschner I, Tu Y K, Gralla R J, Gebski V, Mok T, Yang J C Gefitinib or erlotinib vs chemotherapy for EGFR mutation-positive lung cancer: individual patient data meta-analysis of overall survival. Journal of the National Cancer Institute 2017;  109 (6)

Lee CK, Man J, Lord S, Links M, Gebski V, Mok T, Yang JCH Checkpoint inhibitors in metastatic EGFR-mutated non–small cell lung cancer—a meta-analysis. Journal of Thoracic Oncology 2017;  12 (2): 403–407.

Lee Y C, Bressel M, Grant P, Russell P, Smith C, Picken S, Camm S, Kiely B E, Milne R L, McLachlan S A, Hickey M, Friedlander M L, Hopper J L, Phillips K A Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer. Familial Cancer 2017;

Leong T, Smithers B M, Haustermans K, Michael M, Gebski V, Miller D, Zalcberg J, Boussioutas A, Findlay M, O'Connell R L, Verghis J, Willis D, Kron T, Crain M, Murray W K, Lordick F, Swallow C, Darling G, Simes J, Wong R TOPGEAR: a randomized, phase III trial of perioperative ECF chemotherapy with or without preoperative chemoradiation for resectable gastric cancer: interim results from an international, intergroup trial of the AGITG, TROG, EORTC and CCTG. Annals of Surgical Oncology 2017;  24 (8): 2252–2258.

Lester A, Rapkins R, Nixdorf S, Khasraw M, McDonald K Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?. Clinical and Translational Oncology 2017;  19 (3): 273–278.

Liang L, Bernhardsson S, Vernooij R W M, Armstrong M J, Bussières A, Brouwers M C, Gagliardi A R, Alhabib S, Fleuren M, Fortino M, Mazza D, O'Rourke N, Willson M Use of theory to plan or evaluate guideline implementation among physicians: A scoping review. Implementation Science 2017;  12 (1): 26. Full text

Liew G, Benitez-Aguirre P, Craig M E, Jenkins A J, Hodgson L A B, Kifley A, Mitchell P, Wong T Y, Donaghue K Progressive retinal vasodilation in patients with type 1 diabetes: a longitudinal study of retinal vascular geometry. Investigative Ophthalmology and Visual Science 2017;  58 (5): 2503–2509.

Lindemann K, Gibbs E, Avall-Lundqvist E, dePont Christensen R, Woie K, Kalling M, Auranen A, Grenman S, Hoegberg T, Rosenberg P, Skeie-Jensen T, Hjerpe E, Dorum A, Gebski V, Kristensen G Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist). British Journal of Cancer 2017;  116 (4): 455–463.

Lindemann K, Kok P S, Stockler M, Sykes P, Brand A Enhanced recovery after surgery for suspected ovarian malignancy a survey of perioperative practice among gynecologic oncologists in Australia and New Zealand to inform a clinical trial. International Journal of Gynecological Cancer 2017;  27 (5): 1046–1050.

Lo B H, Klopper F, Barnes E H, Williams K Agreement between concern about autism spectrum disorder at the time of referral and diagnosis, and factors associated with agreement. Journal of Paediatrics and Child Health 2017;

Luckett T, Spencer L, Morton R L, Pollock C A, Lam L, Silvester W, Sellars M, Detering K M, Butow P N, Tong A, Clayton J M Advance care planning in chronic kidney disease: a survey of current practice in Australia. Nephrology (Carlton) 2017;  22 (2): 139–149. Full text

Ma R C, Tsoi K Y, Tam W H, Wong C K Developmental origins of type 2 diabetes: a perspective from China. European Journal of Clinical Nutrition 2017;  71 (7): 870–880.

McAuley S A, Ward G M, Horsburgh J C, Gooley J L, Jenkins A J, MacIsaac R J, O'Neal D N Asymmetric changes in circulating insulin levels after an increase compared with a reduction in insulin pump basal rate in people with type 1 diabetes. Diabetic Medicine 2017;  34 (8): 1158–1164.

Meher S, Duley L, Hunter K, Askie L Antiplatelet therapy before or after 16 weeks gestation for preventing preeclampsia: an individual participant data meta-analysis. American Journal of Obstetrics and Gynecology 2017;  216 (2): 121–128 e2.

Mehr S, Frith K, Barnes E H, Campbell D E Food protein induced enterocolitis syndrome in Australia: A population based study 2012–2014. Journal of Allergy and Clinical Immunology 2017;

Mercieca-Bebber R, Friedlander M, Kok P S, Calvert M, Kyte D, Stockler M, King M T The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols (vol 25, pg 2457, 2016) [erratum]. Quality of Life Research 2017;  26 (8): 2249–2250. Full text

Morton RL, Tran A, Vessey JY, Rowbotham N, Winstanley J, Shannon K, Spillane AJ, Stretch J, Thompson JF, Saw RPM Quality of life following sentinel node biopsy for primary cutaneous melanoma: health economic implications. Annals of Surgical Oncology 2017;  24 (8): 2071–2079.

Moth E B, Kiely B E, Naganathan V, Martin A, Blinman P How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists. Supportive Care in Cancer 2017;

Oei J L, Saugstad O D, Lui K, Wright I M, Smyth J P, Craven P, Wang Y A, McMullan R, Coates E, Ward M, Mishra P, De Waal K, Travadi J, See K C, Cheah I G, Lim C T, Choo Y M, Kamar A A, Cheah F C, Masoud A, Tarnow-Mordi W Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial. Pediatrics 2017;  139 (1)

Oei J L, Vento M, Rabi Y, Wright I, Finer N, Rich W, Kapadia V, Aune D, Rook D, Tarnow-Mordi W, Saugstad O D Higher or lower oxygen for delivery room resuscitation of preterm infants below 28 completed weeks gestation: a meta-analysis. Archives of Disease in Childhood. Fetal and Neonatal Edition 2017;  102 (1): F24–F30. Full text

Ong K L, O'Connell R, Januszewski A S, Jenkins A J, Xu A, Sullivan D R, Barter P J, Scott R S, Taskinen M R, Waldman B, Colman P G, Best J D, Simes J R, Rye K A, Keech A C Baseline circulating FGF21 concentrations and increase after fenofibrate treatment predict more rapid glycemic progression in type 2 diabetes: results from the FIELD study. Clinical Chemistry 2017;  63 (7): 1261–1270.

Pellise M, Burgess N G, Tutticci N, Hourigan L F, Zanati S A, Brown G J, Singh R, Williams S J, Raftopoulos S C, Ormonde D, Moss A, Byth K, P'Ng H, Mahajan H, McLeod D, Bourke M J Endoscopic mucosal resection for large serrated lesions in comparison with adenomas: a prospective multicentre study of 2000 lesions. Gut 2017;  66 (4): 644–653.

Petrie J R, Chaturvedi N, Ford I, Brouwers MCJI, Greenlaw N, Tillin T, Hramiak I, Hughes A D, Jenkins A J, Klein B E K, Klein R, Ooi T C, Rossing P, Stehouwer C D A, Sattar N, Colhoun H M Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. Lancet Diabetes & Endocrinology 2017;  19 (4): 509–516. Full text

Petrie J R, Chaturvedi N, Ford I, Hramiak I, Hughes A D, Jenkins A J, E Klein B, Klein R, Ooi T C, Rossing P, Sattar N, Stehouwer C D A, Colhoun H M, on behalf of the REMOVAL Trial Team. Metformin in adults with type 1 diabetes: design and methods of Reducing with Metformin Vascular Adverse Lesions (REMOVAL): an international multicentre trial. Diabetes, Obesity and Metabolism 2017;  19 (4): 509–516. Full text

Phillips C, Jeffree R, Khasraw M Management of breast cancer brain metastases: a practical review. Breast 2017;  31: 90–98.

Phillips C, Jeffree R, Khasraw M Reply to Dr Altundag from the authors of ‘Management of breast cancer brain metastases; a practical review’ [letter]. Breast 2017;  34: 133.

Pickering H, Murray J, Lin C S, Cormack C, Martin A, Kiernan M C, Krishnan A V Fampridine treatment and walking distance in multiple sclerosis: A randomised controlled trial. Clinical Neurophysiology 2017;  128 (1): 93–99.

Popat H, Robledo KP Sebastian L, Evans N, Gill A, Kluckow M, Sinhal S, de Waal K, Tarnow-Mordi W, Osborn D Interobserver agreement and image quality of functional cardiac ultrasound measures used in a randomised trial of delayed cord clamping in preterm infants. Archives of Disease in Childhood: Fetal and Neonatal Edition 2017;

Potter J E, Herkes R G, Perry L, Elliott R M, Aneman A, Brieva J L, Cavazzoni E, Cheng A T, O'Leary M J, Seppelt I M, Gebski V Communication with families regarding organ and tissue donation after death in intensive care (COMFORT): protocol for an intervention study. BMC Health Services Research 2017;  17 (1): 42. Full text

Pottie K, Welch V, Morton R, Akl E A, Eslava-Schmalbach J H, Katikireddi V, Singh J, Moja L, Lang E, Magrini N, Thabane L, Stanev R, Matovinovic E, Snellman A, Briel M, Shea B, Tugwell P, Schunemann H, Guyatt G, Alonso-Coello P GRADE Equity Guidelines 4: Guidance on how to assess and address health equity within the evidence to decision process. Journal of Clinical Epidemiology 2017;

Rakhimova G N, Alimova N U, Ryaboshtan A, Waldman B, Ogle G D, Ismailov S I Epidemiological data of type 1 diabetes mellitus in children in Uzbekistan, 1998–2014. Pediatric Diabetes 2017;

Read S A, O'Connor K S, Suppiah V, Ahlenstiel C L E, Obeid S, Cook K M, Cunningham A, Douglas M W, Hogg P J, Booth D, George J, Ahlenstiel G Zinc is a potent and specific inhibitor of IFN-lambda3 signalling. Nature Communications 2017;  8: 15245. Full text

Roncolato F T, Gibbs E, Lee C K, Asher R, Davies L C, Gebski V J, Friedlander M, Hilpert F, Wenzel L, Stockler M R, King M, Pujade-Lauraine E Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy. Annals of Oncology 2017;

Roncolato F T, Joly F, O'Connell R, Lanceley A, Hilpert F, Buizen L, Okamoto A, Aotani E, Pignata S, Donnellan P, Oza A, Avall-Lundqvist E, Berek J S, Heitz F, Feeney A, Berton-Rigaud D, Stockler M R, King M, Friedlander M Reducing uncertainty: predictors of stopping chemotherapy early and shortened survival time in platinum resistant/refractory ovarian cancer: the GCIG Symptom Benefit study. Oncologist 2017;

Sabanathan D, Zhang A, Fox P, Coulter S, Gebski V, Balakrishnar B, Chan M, Liddle C, Gurney H Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring. Cancer Chemotherapy and Pharmacoloogy 2017;  802 (385–393)

Sabanayagam C, Lye W K, Januszewski A, Banu Binte Mohammed Abdul R, Cheung G C M, Kumari N, Wong T Y, Cheng C Y, Lamoureux E Urinary isoprostane levels and age-related macular degeneration. Investigative Ophthalmology and Visual Science 2017;  58 (5): 2538–2543. Full text

Sabatine M S, Giugliano R P, Keech A C, Honarpour N, Wiviott S D, Murphy S A, Kuder J F, Wang H, Liu T, Wasserman S M, Sever P S, Pedersen T R Evolocumab and clinical outcomes in patients with cardiovascular disease. New England Journal of Medicine 2017;  376 (18): 1713–1722.

Scott AM Health technology assessment in Australia: a role for clinical registries?. Australian Health Review 2017;  41 (1): 19–25.

Sellars M, Tong A, Luckett T, Morton R L, Pollock C A, Spencer L, Silvester W, Clayton J M Clinicians' perspectives on advance care planning for patients with CKD in Australia: an interview study. American Journal of Kidney Diseases 2017;

Smit A K, Keogh L A, Newson A J, Butow P N, Dunlop K, Morton R L, Kirk J, Espinoza D, Cust A E Does personalised melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals?. British Journal of Dermatology 2017;

Smit AK, Espinoza D, Newson AJ, Morton RL, Fenton G, Freeman L, Dunlop K, Butow PN, Law MH, Kimlin MG, Keogh LA, Dobbinson SJ, Kirk J, Kanetsky PA, Mann GJ, Cust AE A pilot randomised controlled trial of the feasibility, acceptability and impact of giving information on personalised genomic risk of melanoma to the public. Cancer Epidemiology Biomarkers & Prevention 2017;  26 (2): 212–221.

Sorio R, Roemer-Becuwe C, Hilpert F, Gibbs E, Garcia Y, Kaern J, Huizing M, Witteveen P, Zagouri F, Coeffic D, Luck H J, Gonzalez-Martin A, Kristensen G, Levache C B, Lee C K, Gebski V, Pujade-Lauraine E Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: subgroup analysis of the randomised phase III AURELIA trial. Gynecologic Oncology 2017;  144 (1): 65–71.

Stewart R A H, Colquhoun D M, Marschner S L, Kirby A C, Simes J, Nestel P J, Glozier N, O'Neil A, Oldenburg B, White H D, Tonkin A M Persistent psychological distress and mortality in patients with stable coronary artery disease. Heart 2017;

Tan A C, Heimberger A B, Khasraw M Immune checkpoint inhibitors in gliomas. Current Oncology Reports 2017;  19 (4): 23.

Tan JWL, Valerio C, Barnes E H, Turner P J, Van Asperen P A, Kakakios A M, Campbell D E A randomized trial of egg introduction from 4 months of age in infants at risk for egg allergy. Journal of Allergy and Clinical Immunology 2017;  139 (5): 1621–1628 e8. Full text

Tarnow-Mordi W, Cruz M, Morris J M, Mol B W RCT evidence should drive clinical practice: a day without randomisation is a day without progress. BJOG: International Journal of Obstetrics and Gynaecology 2017;  124 (4): 613. Full text

Tattersall M H, Jefford M, Martin A, Olver I, Thompson J F, Brown R F, Butow P N Parallel multicentre randomised trial of a clinical trial question prompt list in patients considering participation in phase 3 cancer treatment trials. BMJ Open 2017;  7 (3): e012666.

Tong P L, West N P, Cox A J, Gebski V J, Watts A M, Dodds A, de St Groth B F, Cripps A W, Shumack S Oral supplementation with bovine whey-derived Ig-rich fraction and lactoferrin improves SCORAD and DLQI in atopic dermatitis. Journal of Dermatological Science 2017;  85 (2): 143–146.

Umrani M R, Joglekar M V, Glover E S, Wong W, Hardikar A A Connexins and microRNAs: interlinked players in regulating islet function?. Islets 2017; : e1331192.

van Vliet E O, Askie L A, Mol B W, Oudijk M A Antiplatelet agents and the prevention of spontaneous preterm birth: A systematic review and meta-analysis. Obstetrics and Gynecology 2017;  129 (2): 327–336.

Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart J J, Lameire N, Morton R L, Oberbauer R, Postma M J, Tonelli M, Biesen W V, Zoccali C Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nature Reviews Nephrology 2017;  13 (7): 393–409.

Vasista A, Stockler M R, West T, Wilcken N, Kiely B E More than just the median: calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials. Breast 2017;  31: 99–104.

Velentzis L S, Caruana M, Simms K T, Lew J B, Shi J F, Saville M, Smith M A, Lord S J, Tan J, Bateson D, Quinn M, Canfell K How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country. International Journal of Cancer 2017;

Virdee SP, Moschandreas J, Gebski V, Love BS, Francis AE, Wasan SH, van Hazel G, Gibbs P, Sharma AR Protocol for combined analysis of FOXFIRE, SIRFLOX, and FOXFIRE-global randomized phase III trials of chemotherapy ± selective internal radiation therapy as first-line treatment for patients with metastatic colorectal cancer. JMIR Research Protocols 2017;  6 (3): e43. Full text

Walker R C, Howard K, Morton R L Home hemodialysis: a comprehensive review of patient-centered and economic considerations. Clinicoeconomics and Outcomes Research 2017;  9: 149–161.

Walker R C, Walker S, Morton R L, Tong A, Howard K, Palmer S C Maori patients' experiences and perspectives of chronic kidney disease: a New Zealand qualitative interview study. BMJ Open 2017;  7 (1): e013829. Full text

Wang M, Chua S C, Bouhadir L, Treadwell E L, Gibbs E, McGee T M Point-of-care measurement of fetal blood lactate: time to trust a new device. Australian & New Zealand Journal of Obstetrics and Gynaecology 2017;

Wasan H S, Gibbs P, Sharma N K, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee P S, Dutton P, Love S, Gebski V, Gray A, van Hazel G, Sharma R A First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. Lancet Oncology 2017;

Watts C G, Cust A E, Menzies S W, Mann G J, Morton R L Cost-effectiveness of skin surveillance through a specialized clinic for patients at high risk of melanoma. Journal of Clinical Oncology 2017;  35 (1): 63–71.

Watts C G, Madronio C, Morton R L, Goumas C, Armstrong B K, Curtin A, Menzies S W, Mann G J, Thompson J F, Cust A E Clinical features associated with individuals at higher risk of melanoma: A population-based study. JAMA Dermatology 2017;  153 (1): 23–29.

Webster A C, Nagler E V, Morton R L, Masson P Chronic kidney disease. Lancet 2017;  389 (10075): 1238–1252.

Welch V A, Akl E A, Pottie K, Ansari M T, Briel M, Christensen R, Dans A, Dans L, Eslava-Schmalbach J H, Guyatt G, Hultcrantz M, Jull J, Katikireddi S V, Lang E, Matovinovic E, Meerpohl J J, Morton R, Mosdol A, Murad M H, Petkovic J, Schunemann H, Sharaf R, Shea B, Singh J A, Sola I, Stanev R, Stein A T, Thabane L, Tonia T, Tristan M, Vitols S, Watine J, Tugwell P GRADE Equity Guidelines 3: Health equity considerations in rating the certainty of synthesized evidence. Journal of Clinical Epidemiology 2017;

Wetzig N, Gill P G, Espinoza D, Mister R, Stockler M R, Gebski V J, Ung O A, Campbell I, Simes J Sentinel-lymph-node-based management or routine axillary clearance? Five-year outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 trial: assessment and incidence of true lymphedema. Annals of Surgical Oncology 2017;  24 (4): 1064–1070.

Whittaker S, Madani D, Joshi S, Chung S A, Johns T, Day B, Khasraw M, McDonald K L Combination of palbociclib and radiotherapy for glioblastoma. Cell Death Discovery 2017;  3: 17033. Full text

Wiedmann M K H, Brunborg C, Di Ieva A, Lindemann K, Johannesen T B, Vatten L, Helseth E, Zwart J A The impact of body mass index and height on the risk for glioblastoma and other glioma subgroups: a large prospective cohort study. Neuro-Oncology 2017;  19 (7): 976–985.

Willson M L, Vernooij R W, Gagliardi A R Questionnaires used to assess barriers of clinical guideline use among physicians are not comprehensive, reliable or valid: a scoping review. Journal of Clinical Epidemiology 2017;  86 (25–38)

Wilson A, Vento M, Shah P, Saugstad O, Finer N, Rich W, Morton R, Rabi Y, Tarnow-Mordi W, Suzuki K, Wright I M, Oei J A review of international clinical practice guidelines for the use of oxygen in the delivery room resuscitation of preterm infants. Acta Paediatrica 2017;

Zalewski K, Lindemann K, Halaska M J, Zapardiel I, Laky R, Chereau E, Lindquist D, Polterauer S, Sukhin V, Dursun P A call for new communication channels for gynecological oncology trainees: a survey on social media use and educational needs by the european network of young gynecological oncologists. International Journal of Gynecological Cancer 2017;  27 (3): 620–626.

Zhang A Y, Judson I, Benson C, Wunder J S, Ray-Coquard I, Grimer R J, Quek R, Wong E, Miah A B, Ferguson P C, Dufresne A, Teh J Y H, Stockler M, Tattersall M H N Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study. British Journal of Cancer 2017;

Zhou B, Hogg P J, Grater F One-Way allosteric communication between the two disulfide bonds in tissue factor. Biophysical Journal 2017;  112 (1): 78–86.